Individualising therapy for drug-sensitive tuberculosis. (2019)
Attributed to:
Tuberculosis Treatment Trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/s2213-2600(19)30247-4
PubMed Identifier: 31427253
Publication URI: http://europepmc.org/abstract/MED/31427253
Type: Journal Article/Review
Volume: 7
Parent Publication: The Lancet. Respiratory medicine
Issue: 10
ISSN: 2213-2600